NovoCure Ltd. (NVCR)
12.53
+2.03
(+19.33%)
USD |
NASDAQ |
Feb 12, 16:00
12.50
-0.03
(-0.24%)
After-Hours: 06:29
NovoCure Cash from Investing (Quarterly) : 71.44M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LivaNova Plc | -23.06M |
| Abbott Laboratories | -- |
| Accuray, Inc. | -- |
| Alphatec Holdings, Inc. | -13.89M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 20.57M |
| Cash from Financing (Quarterly) | 100.52M |
| Free Cash Flow | -65.17M |
| Free Cash Flow Per Share (Quarterly) | 0.1333 |
| Free Cash Flow to Equity (Quarterly) | -82.77M |
| Free Cash Flow to Firm (Quarterly) | 14.92M |
| Free Cash Flow Yield | -4.70% |